Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Similarly, a post-hoc analysis of SURPASS-1, enrolling 478 patients with T2D, found that all doses of tirzepatide as monotherapy increased insulin sensitivity compared to placebo, as suggested by the decreases in HOMA2-IR by 923% (vs +14.7% with placebo) and fasting insulin levels by 212% (vs +15%) and the increase in adiponectin by 1623% (vs 0.2%) and IGFBP-2 by 3870% (vs +4.1%) at 40 weeks [76]
Our experienced healthcare provider can help determine if tirzepatide is the right option for you
doi: 10.1155/2015/126984 328 MackM
When you lose fat, especially visceral fat, inflammation tends to go down too
J Clin Endocrinol Metab (2013) 98(4):E66471
US$ 24.79
US$ 29.70
US$ 24.07
US$ 23.16
US$ 27.41
US$ 29.49
